Program Book

Recommendations

Info

153 UM14 PHENO-GENOTYPIC IDENTIFICATION OF CIRCULATING TUMOR CELLS IN UVEAL MELANOMA Cinzia Mazzini, Pamela Pinzani, Francesca Salvianti, Daniela Massi, Giulia Pieretti, Mario Pazzagli, Daniela Bacherini, Ugo Menchini 12.00-12.30 Poster presentations UMp114-126 (Moderators: J.W. Harbour, G. Chantada) 12.30-14.00 LUNCH 14.00-15.40 Papers (Moderators: T. Kivela, M. Materin) 1245 UM15 PROSPECTIVE FOLLOW-UP STUDY IN HIGH-RISK UVEAL MELANOMA (UM) PATIENTS: FINAL RESULTS. S. Piperno-Neumann, V. Servois, P. Mariani, J. Couturier, C. Plancher, C. Levy-Gabriel, L. Lumbroso-Le Rouic, R. Salmon, B. Asselain, L. Desjardins 3 UM16 PERSONALIZED TARGETED THERAPY FOR UVEAL MELANOMAS HARBORING GNAQ OR GNA11 MUTATIONS Vasiliki Poulaki, Sue Anne Chew, Bin He, Nicholas Mitsiades 132 UM17 RATIONALE, STUDY DESIGN AND ACCRUAL STATUS OF A RANDOMIZED PHASE II STUDY OF AZD6244, A MEK INHIBITOR, VS TEMOZOMJDE IN ADVANCED UVEAL MELANOMA Richard D. Carvajal, Jedd D. Wolchok, Paul B. Chapman, Mark Dickson, Mark Bluth, Grazia Ambrosini, Brian Marr, Murk Heinemann, Annie Fusco, Marta Nalysnyk, Natasha Martin, Austin Doyle, Boris Bastian, David Abramson, Gary K. Schwartz 2212 UM18 A CLINICAL PROBE FOR TRANSSCLERAL OPTICAL SPECTROSCOPY OF INTRAOCULAR TUMOURS J. Krohn, P. Svenmarker, C.T. Xu, S. Andersson-Engels 300 UM19 OUR EXPERIENCE WITH TRANSPUPILLARY THERMO THERAPY FOR SUSPECTED OR SMALL CHOROIDAL MELANOMAS Mordechai Rosner, Iris Moroz , Josef Moisseiev, Victoria Vishnevskia-Dai 1842 UM20 RESECTION OF IRIS TUMOURS : INTERNAL APPROACH Arun D. Singh UVEAL MELANOMA <strong>Program</strong> 92 1917 UM21 PLAQUE RADIOTHERAPY TREATMENT WITH RUTHE- NIUM-106 FOR IRIS MALIGNANT MELANOMA Amit K. Arora, Maria Tsimpida, Victoria M.L. Cohen, John L. Hungerford 1849 UM22 RUTHENIUM BRACHYTHERAPY WITH THE 10 MM PLAQUE FOR SMALL POSTERIOR CHOROIDAL MELANOMAS Tero Kivelä, Susanna Salkola, Sebastian Eskelin, Jorma Heikkonen 63 UM23 REGRESSION OF UVEAL MELANOMA FOLLOWING IODINE 125 PLAQUE RADIOTHERAPY: PREDICTIVE FACTORS AND CORRELATION WITH METASTASIS Hakan Demirci, Fiorella Saponara, Adam Khan, Leslie Niziol, Grant Comer, David Musch 1802 UM24 TUMOUR REGRESSION AFTER BRACHYTHERAPY FOR UVEAL MELANOMA: ASSOCIATION WITH SURVIVAL M.M. Rashid, T. Kivelä 2310 UM 25 RESULTS OF VITREORETINAL SURGERY FOLLOWING A COMPLICATED COURSE AFTER PLAQUE BRACHYTHERAPY OF MALIGNANT MELANOMA OF THE UVEA C. Metz, T. Gkika, W. Sauerwein, N. Bornfeld 2230 UM 26 LONG-TERM RESULTS AFTER ENDORESECTION OF LARGE UVEAL MELANOMAS WITH PRETREATMENT BY SINGLE-DOSE STEREOTACTIC IRRADIATION AND ADJUVANT BRACHYTHERAPY E. Biewald, H. Lautner, M. Freistühler, M. Gök, W. Sauerwein, GA Horstmann, N. Bornfeld 15.40-16.10 BREAK 16.10-17.30 Papers Uveal Melanoma (Moderators: A. Irarrazaval, E. Midena) 1447 UM27 TREATMENT OF JUXTAPAPILLARY CHOROIDAL MELA- NOMA Maria Tsimpida, John Hungerford, Victoria M.L. Cohen
2307 UM28 OPTIC NERVE DAMAGE AFTER IRRADIATION OF INTRAOCULAR TUMOURS Evangelos S. Gragoudas, Anne Marie Lane, Ivana Kim 133 UM29 PROTON BEAM RADIOTHERAPY OF PARAPAPILLARY CHOROIDAL MELANOMA G.D. Willerding, D. Cordini, N.E. Bechrakis, M.H. Foerster, J. Heufelder, A.M. Joussen N. Lakotka, L. Moser 1414 UM30 HEMODYNAMIC MODIFICATIONS OF THE RETINA AND THE CHOROÏD FOLLOWING PROTON BEAM IRRADIATION OF UVEAL MELANOMAS Leonidas Zografos, Ann Schalenbourg, Line Chamot 2358 UM31 PERIOCULAR TRIAMCINOLONE FOR PREVENTION OF MACULAR EDEMA FOLLOWING PLAQUE RADIOTHERAPY OF UVEAL MELANOMA: THREE YEAR FOLLOW-UP Noel Horgan, Carol L. Shields, Melissa Murphy, Arman Mashayekhi, Pedro F. Salazar, Miguel A. Materin, Myra O’Regan, Jerry A. Shields 1825 UM32 INTRAVITREAL BEVACIZUMAB VERSUS TRIAMCINOLONE ACETONIDE INJECTION FOR SEROUS RETINAL DETACHMENT SECONDARY TO POSTERIOR UVEAL MELANOMA Edoardo Midena, Raffaele Parrozzani, Elisabetta Pilotto, Alessia Dario, Giacomo Miglionico UVEAL MELANOMA <strong>Program</strong> 93 2326 UM33 INTRAVITREAL BEVACIZUMAB AS AN ADJUVANT AGENT WHEN USED IMMEDIATELY AFTER TREATMENT WITH PLAQUE BRACHYTHERAPY Samuel K. Houston, Timothy G. Murray, Arnold M. Markoe, Yolanda Pina, Christina Decatur 2040 UM34 INTRAVENOUS AND ORAL STEROID ADMINISTRATION FOR PAIN CONTROL IN PLAQUE PATIENTS: A RANDOMIZED TRIAL A.C. Schefler, D.G. Gologorsky, J. Fulgueira, W. Feuer 1623 UM35 UVEAL MELANOMA AMONG FINNISH CHILDREN AND ADOLESCENTS Rana’a Aljamal, Tero Kivelä 406 UM 36 RESULTS OF MELANOMA BRACHYTHERAPY IN ARGENTINA Arturo Irarrazaval, Pablo Cazon
Page 1 and 2:
XV th NH City Hotel and Tower Boliv
Page 3 and 4:
List of Congress Meetings of the In
Page 5:
Table of Contents Welcome address K
Page 8 and 9:
Keynote Lectures Lymphoma of the oc
Page 10 and 11:
The venue for the Biannual Meeting
Page 12 and 13:
Buenos Aires Downtown MAP 12 Venue
Page 15 and 16:
MORNING 8.30-10.10 Papers (Moderato
Page 17 and 18:
50 RES 26 USING THE GLYCOLYTIC INHI
Page 19 and 20:
2226 RES 4 NOTCH SIGNALING PROMOTES
Page 21 and 22:
a reduction in the number of living
Page 23 and 24:
array further detected copy number
Page 25 and 26:
615 RES 21 TRB2 AND SKP2 IN THE RET
Page 27:
following treatment with 2-fluorode
Page 30 and 31:
1909 Rb14 RESULTS OF PATIENTS WITH
Page 32 and 33:
Posters Retinoblastoma 2006 RBp100
Page 34 and 35:
120 RBp135 MANAGEMENT OF AN ECTOPIC
Page 36 and 37:
After treatment, 10 patients lived
Page 38 and 39:
Methods. Six cycles of carboplatin
Page 40 and 41:
1940 RB15 PROTON THERAPY FOR RECURR
Page 42 and 43: 4. Fluoroscopy for cannula placemen
Page 44 and 45: Methods. A retrospective chart revi
Page 46 and 47: Ruth A. Kleinerman1, Chu-ling Yu1,
Page 48 and 49: 2006 RBp100 RETINOBLASTOMA ASSESSME
Page 50 and 51: months. Mean delay between beginnin
Page 52 and 53: not associated with severity of RB.
Page 54 and 55: Conclusions. During a ten-year peri
Page 56 and 57: 30 RBp127 TREATMENT MODULATION IN R
Page 58 and 59: (follow-up 5 years). Two years afte
Page 61 and 62: 8.30-9.00 Poster presentations ECOp
Page 63 and 64: Uvea (Moderators: B. Damato, M. Sag
Page 65 and 66: Morning 8.30-9.00 Poster presentati
Page 67 and 68: 1621 EC1 EVALUATION OF THE “HEDGE
Page 69 and 70: Purpose. Ocular surface squamous ne
Page 71 and 72: (cargusale@yahoo.com) Oncology Serv
Page 73 and 74: of the tissues most commonly affect
Page 75 and 76: 2128 RF1 RETINOBLASTOMA David H. Ab
Page 77 and 78: Ocular Oncology Service, St Barthol
Page 79 and 80: Arturo Irarrazaval, Pablo Cazon, Os
Page 81 and 82: A CASE OF TEARING AND SWELLING OF T
Page 83 and 84: 1849 ECp101 FIVE CASES OF CARCINOMA
Page 85 and 86: patients. The isolated involvement
Page 87 and 88: exudative fluid from the hemangioma
Page 89: maximum of 7 rituximab injections.
Page 94 and 95: 8.30-9.00 Poster presentations UMp1
Page 96 and 97: 2253 UM1 PRELIMINARY STUDY OF VASCU
Page 98 and 99: Purpose. To determine the presence
Page 100 and 101: gene expression profile of melanocy
Page 102 and 103: the rarity of UM, timely completion
Page 104 and 105: C. Metz, T. Gkika, W. Sauerwein, N.
Page 106 and 107: Patients in the triamcinolone group
Page 108 and 109: 1350 Ump101 INDUCED EXPRESSION OF P
Page 110 and 111: Purpose. To report the Results of R
Page 112 and 113: 1547 Ump113 LONG-TERM OBSERVATIONS
Page 114 and 115: 2038 Ump119 VALUE OF DOPPLER ANALYS
Page 116: Methods. A total of 4070 patients w
Page 119: First authors Naseripour, Masood No
show all

Program Book

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?